Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Activation Confers Functional Neuroprotection in Global Ischemia
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Activation Confers Functional Neuroprotection in Global Ischemia
Authors
Keywords
-
Journal
NEUROTOXICITY RESEARCH
Volume 19, Issue 3, Pages 462-471
Publisher
Springer Nature
Online
2010-06-03
DOI
10.1007/s12640-010-9201-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Neuroimmunomodulation in Alzheimer's Disease
- (2009) Ricardo B. Maccioni et al. Annals of the New York Academy of Sciences
- Time-dependent effects of global cerebral ischemia on anxiety, locomotion, and habituation in rats
- (2009) Marc R. Milot et al. BEHAVIOURAL BRAIN RESEARCH
- PPARγ agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia
- (2009) Seong-Ryong Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat
- (2009) Mohammad Allahtavakoli et al. BRAIN RESEARCH
- Activating Peroxisome Proliferator-Activated Receptor Mutant Promotes Tumor Growth In vivo by Enhancing Angiogenesis
- (2009) L. Tian et al. CANCER RESEARCH
- Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation
- (2009) Federico Biscetti et al. Cardiovascular Diabetology
- The ubiquitin–proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control
- (2009) Raffaele Marfella et al. CARDIOVASCULAR PATHOLOGY
- Neuroinflammation and Neuroprotective Strategies in Acute Ischaemic Stroke - from bench to bedside
- (2009) Imtiaz Shah et al. CURRENT MOLECULAR MEDICINE
- Rosiglitazone Alone Or in Combination with Tissue Plasminogen Activator Improves Ischemic Brain Injury in an Embolic Model in Rats
- (2009) Chen Xu Wang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neuronal PPAR Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia
- (2009) X. Zhao et al. JOURNAL OF NEUROSCIENCE
- Troglitazone Inhibits Vascular Endothelial Growth Factor–Induced Angiogenic Signaling via Suppression of Reactive Oxygen Species Production and Extracellular Signal–Regulated Kinase Phosphorylation in Endothelial Cells
- (2009) Byung Chul Park et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Peroxisome proliferator-activated receptors and angiogenesis
- (2009) F. Biscetti et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis
- (2008) Ahmad Aljada et al. ANGIOGENESIS
- Inflammatory Cytokines in Acute Ischemic Stroke
- (2008) Antonino Tuttolomondo et al. CURRENT PHARMACEUTICAL DESIGN
- Selective Activation of Peroxisome Proliferator-Activated Receptor (PPAR) and PPAR Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor-Dependent Mechanism
- (2008) F. Biscetti et al. DIABETES
- Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice
- (2008) Kazunori Miki et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Effectiveness of PSD95 Inhibitors in Permanent and Transient Focal Ischemia in the Rat
- (2008) Hong-Shuo Sun et al. STROKE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started